BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 11, 2001
View Archived Issues
TheraMed now called MaxCyte
Read More
FDA and EMEA accept Amevive filing for psoriasis
Read More
Modex acquires rights to novel small molecule to protect against radiation-induced skin damage
Read More
Revotar enters licensing agreement with Fraunhofer Institute for MIF
Read More
Phase II trial of Heptazyme for hepatitis C initiated
Read More
Study using Imavist for improved detection of prostate cancer set to begin
Read More
IntraBiotics presents promising results for iseganan in treating ventilator-associated pneumonia
Read More
Companies collaborate on the development of novel Alzheimer's vaccine
Read More
Endogenous brain cannabinoid is neuroprotective in mice with traumatic brain injury
Read More
Adenosine A2A receptor as a new target for antidepressant therapy
Read More
Phase I clinical trial of Esperion's RLT peptide to commence at Mayo Clinic
Read More
Cell Pathways encouraged by rapid progress made in clinical studies of CP-461 for CLL
Read More
TA-0201: a promising new drug for cardiovascular diseases
Read More
Second phase I/II clinical trial of Levulan PDT begins for treatment of Barrett's esophagus
Read More
Orally active, metabolically stable muscarinic M2 antagonist emerges from Schering-Plough screening
Read More
ICAgen seeks partners for pain management program
Read More
Orphan Medical submits amended NDA to FDA for Xyrem
Read More
Novel AEDs validated preclinically available for licensing from ICAgen
Read More
Xenova terminates TA-HSV development, DISC-PRO studies continue
Read More
Clinically used pain medication now claimed for IBS
Read More
Novel combinations claimed by Merck Frosst for depression and anxiety
Read More
Oxamide-based inhibitors of IMPDH under study at Roche
Read More
Dainippon compounds with benzodiazepine receptor subtype selectivity
Read More
Asahi Glass describes novel antiglaucoma difluoroprostaglandins
Read More
Preparation and use of new beta3-adrenoceptor agonists covered in recent patent
Read More
Thyroid hormone receptor ligands in development at Pfizer
Read More